Manchester Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$172K Sell
1,878
-42
-2% -$3.67K 0.02% 310
2026
Q1
$164K Sell
1,920
-111
-5% -$9.89K 0.02% 297
2025
Q4
$160K Sell
2,031
-246
-11% -$19.3K 0.02% 299
2025
Q3
$182K Sell
2,277
-453
-17% -$38.6K 0.02% 322
2025
Q2
$248K Sell
2,730
-390
-13% -$35.6K 0.03% 311
2025
Q1
$292K Buy
3,120
+105
+3% +$9.4K 0.04% 281
2024
Q4
$274K Buy
3,015
+2
+0.1% +$191 0.03% 293
2024
Q3
$313K Sell
3,013
-7
-0.2% -$713 0.04% 281
2024
Q2
$293K Sell
3,020
-47
-2% -$4.34K 0.04% 278
2024
Q1
$276K Buy
3,067
+12
+0.4% +$1.02K 0.03% 274
2023
Q4
$244K Buy
3,055
+198
+7% +$14.9K 0.03% 263
2023
Q3
$203K Sell
2,857
-13
-0.5% -$972 0.03% 264
2023
Q2
$221K Buy
2,870
+33
+1% +$2.55K 0.03% 264
2023
Q1
$213K Sell
2,837
-427
-13% -$31.8K 0.03% 283
2022
Q4
$257K Buy
3,264
+4
+0.1% +$300 0.04% 217
2022
Q3
$229K Sell
3,260
-2
-0.1% -$157 0.04% 200
2022
Q2
$261K Buy
3,262
+49
+2% +$3.83K 0.04% 193
2022
Q1
$244K Buy
3,213
+21
+0.7% +$1.66K 0.04% 230
2021
Q4
$272K Buy
3,192
+237
+8% +$18.5K 0.04% 232
2021
Q3
$223K Sell
2,955
-141
-5% -$11.2K 0.03% 266
2021
Q2
$252K Buy
3,096
+204
+7% +$16.7K 0.03% 241
2021
Q1
$228K Sell
2,892
-99
-3% -$7.76K 0.03% 245
2020
Q4
$256K Buy
2,991
+168
+6% +$13.9K 0.04% 218
2020
Q3
$218K Sell
2,823
-945
-25% -$72.1K 0.03% 213
2020
Q2
$276K Hold
3,768
0.04% 206
2020
Q1
$250K Sell
3,768
-2,000
-35% -$141K 0.04% 201
2019
Q4
$397K Buy
5,768
+800
+16% +$54.5K 0.04% 183
2019
Q3
$365K Hold
4,968
0.04% 181
2019
Q2
$356K Hold
4,968
0.05% 182
2019
Q1
$341K Hold
4,968
0.04% 180
2018
Q4
$322K Hold
4,968
0.05% 171
2018
Q3
$333K Hold
4,968
0.05% 176
2018
Q2
$322K Sell
4,968
-27
-0.5% -$1.77K 0.05% 173
2018
Q1
$358K Buy
4,995
+27
+0.5% +$1.94K 0.06% 155
2017
Q4
$375K Hold
4,968
0.06% 149
2017
Q3
$362K Hold
4,968
0.06% 138
2017
Q2
$368K Hold
4,968
0.06% 134
2017
Q1
$364K Hold
4,968
0.06% 138
2016
Q4
$325K Hold
4,968
0.05% 143
2016
Q3
$368K Hold
4,968
0.06% 143
2016
Q2
$364K Sell
4,968
-850
-15% -$60.5K 0.05% 149
2016
Q1
$411K Sell
5,818
-3,200
-35% -$213K 0.06% 140
2015
Q4
$601K Buy
9,018
+3,200
+55% +$213K 0.08% 101
2015
Q3
$369K Sell
5,818
-13,630
-70% -$890K 0.06% 132
2015
Q2
$1.27M Sell
19,448
-600
-3% -$40.7K 0.2% 43
2015
Q1
$1.39M Sell
20,048
-2,577
-11% -$178K 0.22% 41
2014
Q4
$1.56M Sell
22,625
-784
-3% -$52.9K 0.19% 43
2014
Q3
$1.53M Buy
23,409
+25
+0.1% +$1.65K 0.2% 42
2014
Q2
$1.59M Buy
23,384
+9
+0% +$603 0.21% 47
2014
Q1
$1.52M Buy
23,375
+600
+3% +$37.8K 0.24% 45
2013
Q4
$1.49M Sell
22,775
-557
-2% -$35.6K 0.23% 47
2013
Q3
$1.38M Buy
23,332
+26
+0.1% +$1.54K 0.24% 46
2013
Q2
$1.33M Buy
+23,306
New +$1.38M 0.25% 45

Other funds holding CL

Manchester Capital Management's CL Position: Q2 2026 in Review

Manchester Capital Management reduced its Colgate-Palmolive (CL) stake by 2.2% in Q2 2026, selling an estimated $3.67K and leaving 1,878 shares worth $172K. The position accounts for 0.02% of the portfolio, ranked #310.

Manchester Capital Management first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.59M in Q2 2014. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Manchester Capital Management held 1,878 shares of Colgate-Palmolive worth $172K as of Q2 2026.
  • Manchester Capital Management sold 42 Colgate-Palmolive shares in Q2 2026, an estimated $3.67K.
  • Colgate-Palmolive made up 0.02% of Manchester Capital Management's portfolio in Q2 2026, its #310 holding.
  • Manchester Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Manchester Capital Management's Colgate-Palmolive position peaked at $1.59M in Q2 2014.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.